Andere Sprachen Avicanna Inc.

Aktien

A2PN04

CA05368K1003

AVCN

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:45:03 18.04.2024			% 5 Tage	% 1. Jan.
0,38 ^CAD	-9,52 %		-8,43 %	+8,57 %

10.04.	Avicanna Inc. gibt den Abschluss der Beobachtungsstudie zur realen Anwendung des topischen Gels bekannt	CI
02.04.	Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Avicanna Raises About $2.1 Million in Non-brokered Private Placement	13:37
Avicanna Announces Closing of Non-brokered Private Placement	18.04.
Avicanna Inc. announced that it has received CAD 2.125584 million in funding	18.04.
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study	10.04.
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study	10.04.
Avicanna's Q4 Loss Narrows, Revenue Grows	02.04.
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022	02.04.
Avicanna Reports Full Year 2023 Audited Financial Results	02.04.
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02.04.
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27.03.
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27.03.
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27.03.
Avicanna Inc Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27.03.
Avicanna To Hold Full Year 2023 Earnings Conference Call	26.03.
ThreeD Capital Inc. Announces New YouTube Channel	25.03.
Avicanna Hosts Symposium on Cannabinoid-based Medicine	29.02.
Avicanna Reports New Research Collaboration With Multi-national European-based Pharmaceutical Firm; Down 5.6%	15.02.
Avicanna Reports New Research Collaboration With Multi-national European-based Pharmaceutical Firm	15.02.
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company	15.02.
Avicanna Brief: Announcing New Research Collaboration with a Multi-national European-based Pharmaceutical Company	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Avicanna Inc.

Aktien

A2PN04

CA05368K1003

AVCN

Andere Sprachen

Filter